Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247111 | SCV000312988 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001312260 | SCV001502704 | benign | CHARGE syndrome | 2024-09-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021013 | SCV005027392 | likely benign | Inborn genetic diseases | 2021-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV005044506 | SCV005677101 | uncertain significance | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2024-04-13 | criteria provided, single submitter | clinical testing |